ObvioHealth and RedHill Biopharma Launch First in Kind Remote COVID-19 Therapy Trial Incorporating Highest Level of At-home Patient Monitoring to Date
ObvioHealth, a global virtual research organization or VRO, today announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital data capture to remotely monitor patient vitals.
ObvioHealth Announces Next Generation Virtual Research Platform and Ecosystem
ObvioHealth, a global Virtual Research Organization (VRO), announces its next generation platform offering enhanced remote patient monitoring capabilities for the company’s end-to-end decentralized clinical trial solutions.
ObvioHealth and GI Alliance Partner to Bring Better GI Care to Patients
ObvioHealth, a globalvirtual research organization (VRO), and GI Alliance, one of the nation'slargest independent gastroenterology services organization, jointly announce anew partnership to create better clinical trial experiences through the use ofdecentralized clinical trial designs.
ObvioHealth Secures $17 Million in Latest Investment Round
ObvioHealth, a leading virtual health research organization or VRO, announced today it has raised $17 million in its latest round of financing. This round of financing comes on the heels of a global alliance with a strategic partner announced in March.
Infographic: The People-Centric Path to Better Data
A research study designed around the needs of its participants is more likely to deliver better data, a product of optimized compliance and engagement. By pairing a versatile digital solution with an accommodating protocol design, ObvioHealth can offer maximum convenience to those who matter most: the people who produce the data. The result? A collection of real-world data points and enhanced insights.
Patient Interactions: Sustained Engagement via Digital Communication
In the clinical trial space, patient concerns that must be addressed with tact. Whether delivering potentially life-altering news, or discussing a health-related concern, I find digital interaction to be the most prudent approach to sustaining engagement and reducing dropout. Here are five real-life examples of this strategy at-work.
Real World Data and Evidence Revolutionize Clinical Research
The U.S. FDA is aware the drug approval process can often be strenuous, consuming large amounts of time and money. That’s why they’ve made a commitment to consider real-world evidence in the approval of new drug indications resulting in a more efficient approach for manufacturers.
Going Virtual: Succeeding Where Traditional Clinical Trials Fail
ObvioHealth, a digital CRO, recently completed a clinical trial solely using a virtual site model (no physical site visits) which would have likely proved futile in the traditional study format, of which requires multiple site visits. This article will further analyze the rationale behind this claim.
PI Perspective: Our Formula to Curb Clinical Trial Dropouts
Our team recently completed a clinical trial tasked with measuring the efficacy of a dietary supplement as an intervention for adults with an elevated blood pressure, or stage I hypertension. By employing a hybrid study model, sustaining patient engagement, and reducing resources required of the patient and study team, we successfully beat the dropout allowance.
Infographic: Resource Consumption by Clinical Trial Type
All clinical trials require resource consumption from both the study team and participant. The following infographic will detail the differences in resources required in the digital (hybrid) model compared to that of the traditional “brick and mortar” model.
An Alternate Approach to the Traditional Recruitment Nightmare
Digital patient-centric clinical trials (PCT) are often carried out in the hybrid setting (minimizing site visits and maximizing the use of a virtual site), or the site-less setting (solely using the virtual site). The pairing of a digitalized PCT with social media targeting increases the probability of successful enrollment.
12 questions to ask before participating in a clinical research trial
There are more than 270,000 clinical research trials going on in the U.S. and other countries currently listed on ClinicalTrials.gov. These trials are helping to advance medial research for better treatments of diseases and conditions. However, before decided to participate in one, there are a number of items to consider first.
Diversity in Clinical Trial Enrollment: Exploring the Roadblocks to Minority Participation in Clinical Research
In the first part of our two-piece series exploring minority participation in clinical trial research, we examine the numerous challenges to securing diversity in clinical trials, and the consequences of primarily white patient populations.
If I participate in a clinical trial how will my data be used?
Data collected from you as a participant is called individual participant data (IPD), that information is transformed into de-identified data when researchers do their analyses, meaning the ability to determine the identity of an individual participant is removed from the data.